Bergers Gabriele, Fendt Sarah-Maria
Laboratory of Tumor Microenvironment and Therapeutic Resistance, VIB-KU Leuven Center for Cancer Biology, Department of Oncology, KU Leuven, Leuven, Belgium.
UCSF Comprehensive Cancer Center, Department of Neurological Surgery, UCSF, San Francisco, CA, USA.
Nat Rev Cancer. 2021 Mar;21(3):162-180. doi: 10.1038/s41568-020-00320-2. Epub 2021 Jan 18.
Metastasis formation is the major cause of death in most patients with cancer. Despite extensive research, targeting metastatic seeding and colonization is still an unresolved challenge. Only recently, attention has been drawn to the fact that metastasizing cancer cells selectively and dynamically adapt their metabolism at every step during the metastatic cascade. Moreover, many metastases display different metabolic traits compared with the tumours from which they originate, enabling survival and growth in the new environment. Consequently, the stage-dependent metabolic traits may provide therapeutic windows for preventing or reducing metastasis, and targeting the new metabolic traits arising in established metastases may allow their eradication.
转移灶的形成是大多数癌症患者死亡的主要原因。尽管进行了广泛研究,但针对转移播种和定植的治疗仍是一项未解决的挑战。直到最近,人们才开始关注这样一个事实,即转移中的癌细胞在转移级联反应的每个步骤中都会选择性地、动态地调整其代谢。此外,许多转移灶与其原发肿瘤相比表现出不同的代谢特征,从而使其能够在新环境中存活和生长。因此,阶段依赖性代谢特征可能为预防或减少转移提供治疗窗口,而针对已形成转移灶中出现的新代谢特征可能会将其根除。